Project Number GC-201904-2018171 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2017 View Full Project Details for Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Cognitive Impairment - Expansion to an additional clinical site Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator Pereira, Ana Principal Investigator First Name Ana Principal Investigator Last Name Pereira Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement Program to Accelerate Clinical Trials (PACT) RFP FY Overall Cost $106,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
